Connect with us

Health

Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure – News-Medical.Net

Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately,…

Published

on

Article feature image

Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures.
In an analysis published in the Journal of Bone and Mineral Research that examined 1997-2013 records from two large U.S. databases, investigators found that EPO doses administered to patients with kidney failure on hemodialysis fluctuated widely over time, and hip fracture…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
South Africa starts vaccinating its elderly against COVID-19 – KIRO Seattle
Article feature image
COVID vaccines: some fully vaccinated people will still get infected – here’s why – The Conversation UK